Vaccines and therapeutics are urgently wanted for the pandemic brought on by extreme acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Right here, we display screen human monoclonal antibodies (mAb) focusing on the receptor binding area (RBD) of the viral spike protein through antibody library constructed from peripheral blood mononuclear cells of a convalescent affected person. The CT-P59 mAb potently neutralizes SARS-CoV-2 isolates together with the D614G variant with out antibody-dependent enhancement impact.
Advanced crystal construction of CT-P59 Fab/RBD exhibits that CT-P59 blocks interplay areas of RBD for angiotensin changing enzyme 2 (ACE2) receptor with an orientation that’s notably totally different from beforehand reported RBD-targeting mAbs. Moreover, therapeutic results of CT-P59 are evaluated in three animal fashions (ferret, hamster, and rhesus monkey), demonstrating a considerable discount in viral titer together with alleviation of scientific signs. Due to this fact, CT-P59 could also be a promising therapeutic candidate for COVID-19.
Atypical Ebola Virus Illness in a Nonhuman Primate following Monoclonal Antibody Remedy Is Related to Glycoprotein Mutations inside the Fusion Loop
Ebola virus (EBOV) is chargeable for quite a few devastating outbreaks all through Africa, together with the 2013-2016 West African outbreak in addition to the 2 current outbreaks within the Democratic Republic of the Congo (DRC), certainly one of which is ongoing. Though EBOV illness (EVD) has sometimes been thought-about a extremely deadly acute an infection, rising proof means that the virus can persist in sure immune-privileged websites and infrequently result in EVD recrudescence.
Little is known concerning the processes that contribute to EBOV persistence and recrudescence, partially due to the rarity of those phenomena but additionally due to the absence of an animal mannequin that recapitulates them. Right here, we describe a case of EBOV persistence related to atypical EVD in a nonhuman primate (NHP) following inoculation with EBOV and therapy with an experimental monoclonal antibody cocktail.
Though this animal exhibited solely delicate indicators of acute EVD, it developed extreme illness 2 weeks later and succumbed shortly thereafter. Viremia was undetectable on the time of dying, regardless of ample ranges of viral RNA in most tissues, every of which appeared to harbor a definite viral quasispecies. Remarkably, sequence evaluation recognized a single mutation in glycoprotein (GP) that not solely resisted antibody-mediated neutralization but additionally elevated viral development kinetics and virulence. Total, this report represents essentially the most completely characterised case of atypical EVD in an NHP described up to now, and it offers worthwhile perception into components which will contribute to EBOV persistence and recrudescent illness.
IMPORTANCE Ebola virus stays a worldwide menace to public well being and biosecurity, but we nonetheless know comparatively little about its pathogenesis and the problems that come up following restoration. With practically 20,000 survivors from the 2013-2016 West African outbreak, in addition to over 1,000 survivors of the current outbreak within the DRC, we should contemplate the results of virus persistence and recrudescent illness, even when they’re uncommon.

On this examine, we describe a case of atypical Ebola virus illness in a nonhuman primate after therapy with a monoclonal antibody. Not solely does this examine underscore the potential for atypical illness shows, nevertheless it additionally emphasizes the significance of contemplating how medical countermeasures may relate to those phenomena, particularly as antibodies are integrated into the usual of care. The outcomes introduced herein present a basis from which we are able to proceed to analyze these sides of Ebola virus illness.
Immunomodulatory potential of anti-idiotypic antibodies for the therapy of autoimmune ailments
The immune system is a fancy community of specialised cells and organs that recognises and reacts in opposition to international pathogens whereas remaining unresponsive to host tissues. This potential to self-tolerate is called immunological tolerance. Autoimmune illness happens when the immune system fails to distinguish between self and non-self antigens and releases autoantibodies to assault our personal cells.
Anti-idiotypic (anti-ID) antibodies are necessary in sustaining a balanced idiotypic regulatory community by neutralising and inhibiting the secretion of autoantibodies. Lately, anti-ID antibodies have been superior instead type of immunotherapy as they will particularly goal autoantibodies, trigger much less toxicity and unwanted side effects, and will present long-lasting immunity. This overview article discusses the immunomodulatory potential of anti-ID antibodies for the therapy of autoimmune ailments.
Bispecific Antibody Inhalation Remedy for Redirecting Stem Cells from the Lungs to Restore Coronary heart Harm
Stem cell remedy is a promising technique for cardiac restore. Nonetheless, scientific efficacy is hampered by poor cell engraftment and the elusive restore mechanisms of the transplanted stem cells. The lung is a reservoir of hematopoietic stem cells (HSCs) and a significant biogenesis web site for platelets. A technique is sought to redirect lung resident stem cells to the injured coronary heart for therapeutic restore after myocardial infarction (MI). To realize this purpose, CD34-CD42b platelet-targeting bispecific antibodies (PT-BsAbs) are designed to concurrently acknowledge HSCs (through CD34) and platelets (through CD42b). After inhalation supply, PT-BsAbs attain the lungs and conjoined HSCs and platelets. As a result of innate injury-finding potential of platelets, PT-BsAbs information lung HSCs to the injured coronary heart after MI.
Mouse LIF |
|
300-365P-500ug |
GeminiBio |
500 µg |
Ask for price |
Mouse LIF |
|
300-365P-5ug |
GeminiBio |
5 µg |
Ask for price |
LIF,Mouse |
|
E34M066M |
EnoGene |
5 μg |
EUR 155 |
LIF, mouse |
|
MO16102 |
Neuromics |
100 ug |
EUR 494.1 |
LIF, Mouse |
|
MBS8575391-0005mg |
MyBiosource |
0.005mg |
EUR 245 |
LIF, Mouse |
|
MBS8575391-5x0005mg |
MyBiosource |
5x0.005mg |
EUR 940 |
Mouse Anti-Human LIF Monoclonal Antibody |
|
MBS592457-01mg |
MyBiosource |
0.1mg |
EUR 365 |
Mouse Anti-Human LIF Monoclonal Antibody |
|
MBS592457-05mg |
MyBiosource |
0.5mg |
EUR 530 |
Mouse Anti-Human LIF Monoclonal Antibody |
|
MBS592457-5x05mg |
MyBiosource |
5x0.5mg |
EUR 2140 |
Mouse Anti-Human LIF Monoclonal Antibody |
|
MBS592458-01mg |
MyBiosource |
0.1mg |
EUR 365 |
Mouse Anti-Human LIF Monoclonal Antibody |
|
MBS592458-05mg |
MyBiosource |
0.5mg |
EUR 530 |
Mouse Anti-Human LIF Monoclonal Antibody |
|
MBS592458-5x05mg |
MyBiosource |
5x0.5mg |
EUR 2140 |
Mouse Anti-Human LIF Monoclonal Antibody |
|
MBS592459-01mg |
MyBiosource |
0.1mg |
EUR 365 |
Mouse Anti-Human LIF Monoclonal Antibody |
|
MBS592459-05mg |
MyBiosource |
0.5mg |
EUR 530 |
Mouse Anti-Human LIF Monoclonal Antibody |
|
MBS592459-5x05mg |
MyBiosource |
5x0.5mg |
EUR 2140 |
Mouse LIF (AF) |
|
300-838P-100ug |
GeminiBio |
100 µg |
Ask for price |
Mouse LIF (AF) |
|
300-838P-1mg |
GeminiBio |
1 mg |
Ask for price |
Mouse LIF (AF) |
|
300-838P-20ug |
GeminiBio |
20 µg |
Ask for price |
Mouse LIF (AF) |
|
300-838P-500ug |
GeminiBio |
500 µg |
Ask for price |
Mouse LIF (AF) |
|
300-838P-5ug |
GeminiBio |
5 µg |
Ask for price |
Mouse LIF siRNA |
|
20-abx922546 |
Abbexa |
-
Ask for price
-
Ask for price
|
|
|
|
Mouse LIF Protein |
|
E2PD201245 |
EnoGene |
20ug |
EUR 595 |
Mouse LIF Protein |
|
E40MOP1672 |
EnoGene |
20ug |
EUR 495 |
Mouse LIF Protein |
|
E40MOP2026 |
EnoGene |
20ug |
EUR 495 |
Mouse LIF Protein |
|
E40MOP2028 |
EnoGene |
20ug |
EUR 495 |
LIF, Mouse, Monoclonal Antibody, Mouse |
|
MBS555093-01mg |
MyBiosource |
0.1mg |
EUR 745 |
LIF, Mouse, Monoclonal Antibody, Mouse |
|
MBS555093-5x01mg |
MyBiosource |
5x0.1mg |
EUR 3210 |
LIF siRNA (Mouse) |
|
MBS8224619-15nmol |
MyBiosource |
15nmol |
EUR 405 |
LIF siRNA (Mouse) |
|
MBS8224619-30nmol |
MyBiosource |
30nmol |
EUR 565 |
LIF siRNA (Mouse) |
|
MBS8224619-5x30nmol |
MyBiosource |
5x30nmol |
EUR 2450 |
Recombinant Mouse LIF |
|
MBS4159936-001mg |
MyBiosource |
0.01mg |
EUR 230 |
Recombinant Mouse LIF |
|
MBS4159936-01mg |
MyBiosource |
0.1mg |
EUR 560 |
Recombinant Mouse LIF |
|
MBS4159936-1mg |
MyBiosource |
1mg |
EUR 1500 |
Recombinant Mouse LIF |
|
MBS4159936-5x1mg |
MyBiosource |
5x1mg |
EUR 6500 |
Recombinant Mouse LIF |
|
MBS7609292-005mg |
MyBiosource |
0.05mg |
EUR 405 |
Recombinant Mouse LIF |
|
MBS7609292-02mg |
MyBiosource |
0.2mg |
EUR 760 |
Recombinant Mouse LIF |
|
MBS7609292-1mg |
MyBiosource |
1mg |
EUR 2175 |
Recombinant Mouse LIF |
|
MBS7609292-5x1mg |
MyBiosource |
5x1mg |
EUR 8410 |
Recombinant Mouse LIF |
|
P1174-.005 |
ApexBio |
5ug |
EUR 108.8 |
|
Description: Peptides & Proteins|Recombinant Proteins |
Recombinant Mouse LIF |
|
P1174-.1 |
ApexBio |
100ug |
EUR 840.8 |
|
Description: Peptides & Proteins|Recombinant Proteins |
Recombinant Mouse LIF |
|
P1174-.5 |
ApexBio |
500ug |
EUR 1885.6 |
|
Description: Peptides & Proteins|Recombinant Proteins |
Recombinant Mouse LIF |
|
Z200195 |
ABM |
10 µg |
EUR 85 |
|
Description: LIF is a multifunctional secreted glycoprotein that exists in both soluble and matrix-bound forms. It displays biologic activities ranging from the differentiation of myeloid leukemic cells into macrophage lineage to effects on bone metabolism, inflammation, neural development, embryogenesis, and the maintenance of implantation. It is now clear that LIF is related in both structure and mechanism of action to the interleukin IL-6 family of cytokines, which also includes IL-11, ciliary neurotrophic factor, oncostatin M, and cardiotrophin 1. The actions of these cytokines are mediated through specific cell-surface receptors that consist of a unique chain and the shared signal transducing subunit gp130. |
Recombinant Mouse LIF |
|
Z200197 |
ABM |
100 µg |
EUR 385 |
|
Description: LIF is a multifunctional secreted glycoprotein that exists in both soluble and matrix-bound forms. It displays biologic activities ranging from the differentiation of myeloid leukemic cells into macrophage lineage to effects on bone metabolism, inflammation, neural development, embryogenesis, and the maintenance of implantation. It is now clear that LIF is related in both structure and mechanism of action to the interleukin IL-6 family of cytokines, which also includes IL-11, ciliary neurotrophic factor, oncostatin M, and cardiotrophin 1. The actions of these cytokines are mediated through specific cell-surface receptors that consist of a unique chain and the shared signal transducing subunit gp130. |
Recombinant Mouse LIF |
|
Z200199 |
ABM |
1.0 mg |
EUR 1200 |
|
Description: LIF is a multifunctional secreted glycoprotein that exists in both soluble and matrix-bound forms. It displays biologic activities ranging from the differentiation of myeloid leukemic cells into macrophage lineage to effects on bone metabolism, inflammation, neural development, embryogenesis, and the maintenance of implantation (2). It is now clear that LIF is related in both structure and mechanism of action to the interleukin IL-6 family of cytokines, which also includes IL-11, ciliary neurotrophic factor, oncostatin M, and cardiotrophin 1 (2). The actions of these cytokines are mediated through specific cell-surface receptors that consist of a unique chain and the shared signal transducing subunit gp130. |
Recombinant Mouse LIF |
|
Z200485 |
ABM |
100 µg |
EUR 1500 |
|
Description: LIF is a multifunctional secreted glycoprotein that exists in both soluble and matrix-bound forms. It displays biologic activities ranging from the differentiation of myeloid leukemic cells into macrophage lineage to effects on bone metabolism, inflammation, neural development, embryogenesis, and the maintenance of implantation (2). It is now clear that LIF is related in both structure and mechanism of action to the interleukin IL-6 family of cytokines, which also includes IL-11, ciliary neurotrophic factor, oncostatin M, and cardiotrophin 1 (2). The actions of these cytokines are mediated through specific cell-surface receptors that consist of a unique chain and the shared signal transducing subunit gp130. |
LIF Protein, Mouse |
|
UA040061 |
Starter Biotechnology Co Ltd |
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
|
- 5 µg
- 10 µg
- 50 µg
- 100 µg
- 500 µg
- 1 mg
|
Anti-Mouse LIF Antibody |
|
103-M263 |
ReliaTech |
100 µg |
EUR 399 |
|
Description: Based on its helical structure, LIF (Leukemia Inhibitory Factor) is considered a member of the Interleukin-6 family of cytokines. Functionally, it has been implicated in a many physiological processes including development, hematopoiesis, bone metabolism, and inflammation. Some cell types known to express LIF include activated T cells, monocytes, astrocytes, osteoblasts, keratinocytes, regenerating skeletal muscle, mast cells, and fibroblasts. |
Anti-Mouse LIF Antibody |
|
103-PA05S |
ReliaTech |
100 µg |
EUR 126 |
|
Description: Leukemia Inhibitory Factor also called LIF is a lymphoid factor that promotes long-term maintenance of embryonic stem cells by suppressing spontaneous differentiation. Leukemia Inhibitory Factor has several functions such as cholinergic neuron differentiation, control of stem cell pluripotency, bone & fat metabolism, mitogenesis of factor dependent cell lines & promotion of megakaryocyte production in vivo. Human and mouse LIF exhibit a 78% identity in its amino acid sequence. Human LIF is as active on human cells as is it is on mouse cells, though mouse LIF is about 1000 fold less active on human cells, than human LIF. |
LIF (mouse), (recombinant) |
|
MBS566073-1mL |
MyBiosource |
1mL |
EUR 1470 |
LIF (mouse), (recombinant) |
|
MBS566073-5x1mL |
MyBiosource |
5x1mL |
EUR 6555 |
LIF, Mouse Recombinant |
|
L4500 |
GenDepot |
1 MIU/mL |
Ask for price |
Mouse LIF ELISA Kit |
|
E28L0650 |
EnoGene |
96T |
EUR 666.67 |
Mouse LIF ELISA Kit |
|
EK5250 |
SAB |
96 tests |
EUR 599 |
|
|
Mouse LIF ELISA Kit |
|
EML0014 |
Abclonal |
96Tests |
EUR 625.2 |
Mouse LIF shRNA Plasmid |
|
20-abx971321 |
Abbexa |
-
Ask for price
-
Ask for price
|
|
|
|
Lif (NM_008501) Mouse Recombinant Protein |
|
E45M43185M5 |
EnoGene |
20 ug |
EUR 1924.54 |
Lif (NM_008501) Mouse Recombinant Protein |
|
E45M42302E0 |
EnoGene |
20 ug |
EUR 1088.75 |
LIF, Human, Monoclonal Antibody, Mouse |
|
MBS555094-01mg |
MyBiosource |
0.1mg |
EUR 745 |
LIF, Human, Monoclonal Antibody, Mouse |
|
MBS555094-5x01mg |
MyBiosource |
5x0.1mg |
EUR 3210 |
Recombinant Mouse LIF protein |
|
CD00323-5ug |
Jiaxing Korain Biotech Ltd (BT Labs) |
5ug |
EUR 176 |
|
|
|
Description: Leukemia inhibitory factor (LIF) is a member of Interleukin 6 family. This protein is mainly expressed in the trophectoderm of the developing embryo, with its receptor LIFR expressed throughout the inner cell mass. LIF has the capacity to induce terminal differentiation in leukemic cells. Its activities include the induction of hematopoietic differentiation in normal and myeloid leukemia cells, the induction of neuronal cell differentiation, and the stimulation of acute-phase protein synthesis in hepatocytes. LIF is used in mouse embryonic stem cell culture, because that removal of LIF pushes stem cells toward differentiation, but they retain their proliferative potential or pluripotency. It is also used in phase II clinical trial, which can assist embryo implantation in women who have failed to become pregnant despite assisted reproductive technologies (ART). Mature mouse LIF shares 78 % a.a. sequence identity with Human LIF. |
Recombinant Mouse LIF protein |
|
IMP-1308 |
Creative BioMart |
10µg |
EUR 360 |
|
|
|
Description: Recombinant Proteins |
Mouse LIF Recombinant Protein |
|
M30-007 |
ReliaTech |
10 µg |
EUR 99.75 |
|
Description: Leukemia Inhibitory Factor also called LIF is a lymphoid factor that promotes long-term maintenance of embryonic stem cells by suppressing spontaneous differentiation. Leukemia Inhibitory Factor has several functions such as cholinergic neuron differentiation, control of stem cell pluripotency, bone & fat metabolism, mitogenesis of factor dependent cell lines & promotion of megakaryocyte production in vivo. Human and mouse LIF exhibit a 78% identity in its amino acid sequence. Human LIF is as active on human cells as is it is on mouse cells, though mouse LIF is about 1000 fold less active on human cells, than human LIF. Recombinant mouse LIF produced in E. coli is a single, non-glycosylated, polypeptide chain containing 180 amino acids and having a molecular mass of 19.86 kDa. |
Mouse LIF Recombinant Protein |
|
M30-008 |
ReliaTech |
50 µg |
EUR 246.75 |
|
Description: Leukemia Inhibitory Factor also called LIF is a lymphoid factor that promotes long-term maintenance of embryonic stem cells by suppressing spontaneous differentiation. Leukemia Inhibitory Factor has several functions such as cholinergic neuron differentiation, control of stem cell pluripotency, bone & fat metabolism, mitogenesis of factor dependent cell lines & promotion of megakaryocyte production in vivo. Human and mouse LIF exhibit a 78% identity in its amino acid sequence. Human LIF is as active on human cells as is it is on mouse cells, though mouse LIF is about 1000 fold less active on human cells, than human LIF. Recombinant mouse LIF produced in E. coli is a single, non-glycosylated, polypeptide chain containing 180 amino acids and having a molecular mass of 19.86 kDa. |
Recombinant Mouse LIF Protein |
|
MBS1751002-01mg |
MyBiosource |
0.1mg |
EUR 315 |
Recombinant Mouse LIF Protein |
|
MBS1751002-5x01mg |
MyBiosource |
5x0.1mg |
EUR 1270 |
Recombinant Mouse LIF Protein |
|
MBS8249390-001mg |
MyBiosource |
0.01mg |
EUR 230 |
Recombinant Mouse LIF Protein |
|
MBS8249390-005mg |
MyBiosource |
0.05mg |
EUR 480 |
Recombinant Mouse LIF Protein |
|
MBS8249390-05mg |
MyBiosource |
0.5mg |
EUR 2825 |
Recombinant Mouse LIF Protein |
|
MBS8249390-5x05mg |
MyBiosource |
5x0.5mg |
EUR 12640 |
Recombinant Mouse LIF Protein |
|
PKSM041100-100ug |
Elabscience Biotech |
100ug |
EUR 739 |
|
|
|
Description: Mouse |
Recombinant Mouse LIF Protein |
|
PKSM041100-20ug |
Elabscience Biotech |
20ug |
EUR 249 |
|
|
|
Description: Mouse |
Recombinant Mouse LIF Protein |
|
R01400-1 |
BosterBio |
100ug/vial |
EUR 240 |
|
|
|
Description: SPLPI TPVNA TCAIR HPCHG NLMNQ IKNQL AQLNG SANAL FISYY TAQGE PFPNN VEKLC APNMT DFPSF HGNGT EKTKL VELYR MVAYL SASLT NITRD QKVLN PTAVS LQVKL NATID VMRGL LSNVL CRLCN KYRVG HVDVP PVPDH SDKEA FQRKK LGCQL LGTYK QVISV VVQAF |
Recombinant Mouse LIF Protein |
|
PM0130M2 |
Leading Biology |
20 µg |
Ask for price |
|
Description: Leukemia inhibitory factor, or LIF, is an interleukin 6 class cytokine that affects cell growth by inhibiting differentiation. When LIF levels drop, the cells differentiate.LIF derives its name from its ability to induce the terminal differentiation of myeloid leukemic cells, thus preventing their continued growth. Other properties attributed to the cytokine include: the growth promotion and cell differentiation of different types of target cells, influence on bone metabolism, cachexia, neural development, embryogenesis and inflammation. p53 regulated LIF has been shown to facilitate implantation in the mouse model and possibly in humans. It has been suggested that recombinant human LIF might help to improve the implantation rate in women with unexplained infertility. |
LIF Protein, Mouse, Recombinant |
|
E45M52739M0-20-ug |
EnoGene |
20 ug |
EUR 291.15 |
LIF Protein, Mouse, Recombinant |
|
PM52739M0 |
Leading Biology |
-
Ask for price
-
Ask for price
-
Ask for price
|
|
Anti-LIF Antibody, Mouse Monoclonal |
|
MBS8107490-01mL |
MyBiosource |
0.1mL |
EUR 300 |
Anti-LIF Antibody, Mouse Monoclonal |
|
MBS8107490-5x01mL |
MyBiosource |
5x0.1mL |
EUR 1200 |
Mouse LIF, C-His Tag |
|
HA210735 |
HUABIO |
100 µg |
Ask for price |
anti- LIF antibody |
|
FNab09804 |
FN Test |
100µg |
EUR 658.5 |
|
|
|
Description: Antibody raised against LIF |
Mouse LIF PicoKine ELISA Kit |
|
MBS178717-5x96StripWells |
MyBiosource |
5x96-Strip-Wells |
EUR 2755 |
Mouse LIF PicoKine ELISA Kit |
|
MBS178717-96StripWells |
MyBiosource |
96-Strip-Wells |
EUR 600 |
Recombinant Mouse LIF, Tag Free |
|
PM2019-.01 |
ApexBio |
10ug |
EUR 208 |
|
Description: Peptides & Proteins|Recombinant Proteins |
Recombinant Mouse LIF, Tag Free |
|
PM2019-.1 |
ApexBio |
10X10ug |
EUR 784 |
|
Description: Peptides & Proteins|Recombinant Proteins |
Lif ORF Vector (Mouse) (pORF) |
|
ORF049145 |
ABM |
1.0 ug DNA |
EUR 607.2 |
Lif ORF Vector (Mouse) (pORF) |
|
ORF049146 |
ABM |
1.0 ug DNA |
EUR 607.2 |
Mouse LIF Recombinant Rabbit monoclonal Antibody |
|
HA722643B |
HUABIO |
100 µL |
Ask for price |
LIF, Mouse Recombinant , 1MIU/ml |
|
L4500-001 |
GenDepot |
1ml |
EUR 235 |
LIF, Mouse Recombinant , 1MIU/ml |
|
L4500-005 |
GenDepot |
5x1ml |
EUR 890 |
LIF ELISA Kit (Mouse) (OKBB00760) |
|
OKBB00760 |
Aviva Systems Biology |
96 Wells |
EUR 606 |
|
Description: Description of target: Leukemia inhibitory factor, or LIF, is an interleukin 6 class cytokine that affects cell growth by inhibiting differentiation. When LIF levels drop, the cells differentiate. The LIF was mapped gene to 22q11-q12.2 by Southern analysis of a series of mouse/human somatic cell hybrids and by in situ hybridization to the chromosomes of 2 normal males and some individuals with chromosomal rearrangements. The gene maps between the Philadelphia translocation BCR1 and the breakpoint of the translocation in cell line GM2324 at 22q12.2. LIF derives its name from its ability to induce the terminal differentiation of myeloid leukemic cells, thus preventing their continued growth. Other properties attributed to the cytokine include: the growth promotion and cell differentiation of different types of target cells, influence on bone metabolism, cachexia, neural development, embryogenesis and inflammation.;Species reactivity: Mouse;Application: ELISA;Assay info: ;Sensitivity: <10pg/ml |
LIF ELISA Kit (Mouse) (OKEH04045) |
|
OKEH04045 |
Aviva Systems Biology |
96 Wells |
EUR 652.8 |
|
Description: Description of target: LIF has the capacity to induce terminal differentiation in leukemic cells. Its activities include the induction of hematopoietic differentiation in normal and myeloid leukemia cells, the induction of neuronal cell differentiation, and the stimulation of acute-phase protein synthesis in hepatocytes.;Species reactivity: Mouse;Application: ;Assay info: Assay Methodology: Quantitative Sandwich ELISA;Sensitivity: 0.039 ng/mL |
LIF, Mouse Recombinant , 10MIU/ml |
|
L4501-001 |
GenDepot |
1ml |
EUR 1100 |
Purified recombinant Mouse LIF protein |
|
MBS5308803-001mg |
MyBiosource |
0.01mg |
EUR 550 |
Purified recombinant Mouse LIF protein |
|
MBS5308803-5x001mg |
MyBiosource |
5x0.01mg |
EUR 2435 |
Mouse LIF HEK293 Overexpression Lysate |
|
MBS8119752-03mg |
MyBiosource |
0.3mg |
EUR 280 |
Mouse LIF HEK293 Overexpression Lysate |
|
MBS8119752-5x03mg |
MyBiosource |
5x0.3mg |
EUR 1205 |
Mouse LIF HEK293 Overexpression Lysate |
|
MBS8119753-03mg |
MyBiosource |
0.3mg |
EUR 280 |
Mouse LIF HEK293 Overexpression Lysate |
|
MBS8119753-5x03mg |
MyBiosource |
5x0.3mg |
EUR 1205 |
LIFR, Recombinant, Mouse (Leukemia Inhibitory Factor Receptor, LIF Receptor, LIF-R, D-factor/LIF Receptor, CD118) |
|
MBS636029-005mg |
MyBiosource |
0.05mg |
EUR 800 |
LIFR, Recombinant, Mouse (Leukemia Inhibitory Factor Receptor, LIF Receptor, LIF-R, D-factor/LIF Receptor, CD118) |
|
MBS636029-5x005mg |
MyBiosource |
5x0.05mg |
EUR 3455 |
Mouse LIF Recombinant Protein Lyophilized |
|
IMSLIFRLY5UG |
Innovative research |
each |
EUR 317 |
|
|
|
Description: Mouse LIF Recombinant Protein Lyophilized |
Mouse LIF Recombinant Protein Lyophilized |
|
MBS8434242-INQUIRE |
MyBiosource |
INQUIRE |
Ask for price |
Human CellExp? LIF, mouse recombinant |
|
7268-10 |
Biovision |
each |
EUR 444 |
Leukemia Inhibitory Factor (LIF), Mouse |
|
MBS555550-0005mg |
MyBiosource |
0.005mg |
EUR 500 |
Leukemia Inhibitory Factor (LIF), Mouse |
|
MBS555550-001mg |
MyBiosource |
0.01mg |
EUR 670 |
Leukemia Inhibitory Factor (LIF), Mouse |
|
MBS555550-5x001mg |
MyBiosource |
5x0.01mg |
EUR 2855 |
Leukemia Inhibitory Factor (LIF), mouse |
|
PR16102 |
Neuromics |
5 ug |
EUR 310.5 |
Leukemia Inhibitory Factor (LIF), mouse |
|
PR16102-B |
Neuromics |
each |
EUR 436.5 |
Mouse LIF protein, C-His tag |
|
MBS9719051-0005mg |
MyBiosource |
0.005mg |
EUR 115 |
Mouse LIF protein, C-His tag |
|
MBS9719051-002mg |
MyBiosource |
0.02mg |
EUR 165 |
Mouse LIF protein, C-His tag |
|
MBS9719051-01mg |
MyBiosource |
0.1mg |
EUR 295 |
Mouse LIF protein, C-His tag |
|
MBS9719051-1mg |
MyBiosource |
1mg |
EUR 1680 |
Mouse LIF protein, C-His tag |
|
MBS9719051-5x1mg |
MyBiosource |
5x1mg |
EUR 7520 |
Mouse LIF protein, C-His tag |
|
PRP1126-100ug |
Abbkine |
100 μg |
EUR 379 |
|
Description: Mouse LIF protein, C-His tag, expressed in E. coli |
Mouse LIF protein, C-His tag |
|
PRP1126-1mg |
Abbkine |
1 mg |
EUR 2509 |
|
Description: Mouse LIF protein, C-His tag, expressed in E. coli |
Mouse LIF protein, C-His tag |
|
PRP1126-20ug |
Abbkine |
20 μg |
EUR 149 |
|
Description: Mouse LIF protein, C-His tag, expressed in E. coli |
Mouse LIF protein, C-His tag |
|
PRP1126-5ug |
Abbkine |
5 μg |
EUR 59 |
|
Description: Mouse LIF protein, C-His tag, expressed in E. coli |
Mouse LIF ELISA Kit PicoKine® |
|
EK0580 |
BosterBio |
96 wells |
EUR 499 |
|
|
|
Description: Mouse LIF ELISA Kit PicoKine® (96 Tests). Quantitate Mouse Lif in cell culture supernatants, serum and plasma (heparin, EDTA). Sensitivity: 10pg/ml. |
Lif (untagged) - Mouse leukemia inhibitory factor (Lif), transcript variant 1, (10ug) |
|
MC208887 |
Origene Technologies GmbH |
10 µg |
Ask for price |
Lif (untagged) - Mouse leukemia inhibitory factor (Lif), transcript variant 2, (10ug) |
|
MC208888 |
Origene Technologies GmbH |
10 µg |
Ask for price |
Recombinant Mouse Lif Protein, No Tag |
|
E40MOP2217 |
EnoGene |
20ug |
EUR 495 |
Recombinant Mouse Lif Protein, No Tag |
|
MOP2217 |
KMD Bioscience |
-
Ask for price
-
Ask for price
|
|
Anti-Human LIF Antibody |
|
101-M553 |
ReliaTech |
100 µg |
EUR 399 |
|
Description: Based on its helical structure, LIF (Leukemia Inhibitory Factor) is considered a member of the Interleukin-6 family of cytokines. Functionally, it has been implicated in a many physiological processes including development, hematopoiesis, bone metabolism, and inflammation. Some cell types known to express LIF include activated T cells, monocytes, astrocytes, osteoblasts, keratinocytes, regenerating skeletal muscle, mast cells, and fibroblasts. |
Anti-Human LIF Antibody |
|
102-PA05S |
ReliaTech |
100 µg |
EUR 126 |
|
Description: Leukemia Inhibitory Factor also called LIF is a lymphoid factor that promotes long-term maintenance of embryonic stem cells by suppressing spontaneous differentiation. Leukemia Inhibitory Factor has several functions such as cholinergic neuron differentiation, control of stem cell pluripotency, bone & fat metabolism, mitogenesis of factor dependent cell lines & promotion of megakaryocyte production in vivo. Human and mouse LIF exhibit a 78% identity in its amino acid sequence. Human LIF is as active on human cells as is it is on mouse cells, though mouse LIF is about 1000 fold less active on human cells, than human LIF. |
Mouse LIF enzyme-linked immunoassay kit |
|
EM0038 |
HUABIO |
96 Tests |
Ask for price |
Recombinant Mouse Lif Protein, low endotoxin |
|
EPLE-19M |
Creative BioMart |
10ug |
EUR 263.2 |
|
Description: Mouse |
Lif (GFP-tagged) - Mouse leukemia inhibitory factor (Lif) transcript variant 1, (10ug) |
|
MG223120 |
Origene Technologies GmbH |
10 µg |
Ask for price |
Lif (GFP-tagged) - Mouse leukemia inhibitory factor (Lif) transcript variant 2, (10ug) |
|
MG223901 |
Origene Technologies GmbH |
10 µg |
Ask for price |
Lif (Myc-DDK-tagged) - Mouse leukemia inhibitory factor (Lif), transcript variant 1 |
|
MR223120 |
Origene Technologies GmbH |
10 µg |
Ask for price |
Lif (Myc-DDK-tagged) - Mouse leukemia inhibitory factor (Lif), transcript variant 2 |
|
MR223901 |
Origene Technologies GmbH |
10 µg |
Ask for price |
LIF Protein, Mouse, Recombinant (His Tag) |
|
E45M53268M2-100 |
EnoGene |
100 ug |
EUR 1347.4 |
LIF Protein, Mouse, Recombinant (His Tag) |
|
MBS8118864-01mg |
MyBiosource |
0.1mg |
EUR 615 |
LIF Protein, Mouse, Recombinant (His Tag) |
|
MBS8118864-1mg |
MyBiosource |
1mg |
EUR 2530 |
LIF Protein, Mouse, Recombinant (His Tag) |
|
MBS8118864-5x1mg |
MyBiosource |
5x1mg |
EUR 11240 |
LIF Protein, Mouse, Recombinant (His Tag) |
|
PM53268M2 |
Leading Biology |
-
Ask for price
-
Ask for price
|
|
Lif sgRNA CRISPR Lentivector set (Mouse) |
|
K3872501 |
ABM |
3 x 1.0 ug |
EUR 406.8 |
Leukemia Inhibitory Factor, Recombinant, Mouse (LIF, Differentiation-stimulating Factor, D Factor, Lif) |
|
MBS635712-0005mg |
MyBiosource |
0.005mg |
EUR 665 |
Leukemia Inhibitory Factor, Recombinant, Mouse (LIF, Differentiation-stimulating Factor, D Factor, Lif) |
|
MBS635712-5x0005mg |
MyBiosource |
5x0.005mg |
EUR 2845 |
Leukemia Inhibitory Factor (LIF) Polyclonal Antibody (Mouse) |
|
4-PAA085Mu01 |
Cloud-Clone |
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
|
- 20ul
- 100ul
- 200ul
- 1ml
- 10ml
|
|
|
|
Description: A Rabbit polyclonal antibody against Mouse Leukemia Inhibitory Factor (LIF) |
LIF, Leukemia inhibitory factor, murine (mouse) |
|
RC234-18 |
Bio Basic |
5ug |
EUR 125.26 |
|
|
Sunlong Medical™ Mouse LIF ELISA Kit |
|
EL0100Mo-48T |
Sunlong |
48T |
EUR 398 |
Sunlong Medical™ Mouse LIF ELISA Kit |
|
EL0100Mo-96T |
Sunlong |
96T |
EUR 569 |
Mouse Leukemia Inhibitory Factor (LIF) Protein |
|
abx262959-10mg |
Abbexa |
10 mg |
EUR 325 |
Mouse Leukemia Inhibitory Factor (LIF) Protein |
|
abx262959-1mg |
Abbexa |
1 mg |
EUR 3801.6 |
|
|
Mouse Leukemia Inhibitory Factor (LIF) Protein |
|
abx262959-25mg |
Abbexa |
25 mg |
EUR 3287.5 |
Mouse Leukemia Inhibitory Factor (LIF) Protein |
|
abx262959-3x10g |
Abbexa |
3x10 µg |
EUR 393.6 |
|
|
Mouse Leukemia Inhibitory Factor (LIF) Protein |
|
abx262959-3x2g |
Abbexa |
3x2 µg |
EUR 276 |
|
|
Mouse Leukemia Inhibitory Factor (LIF) Protein |
|
abx262959-5mg |
Abbexa |
5 mg |
EUR 225 |
Mouse Leukemia Inhibitory Factor (LIF) Protein |
|
abx067761-100g |
Abbexa |
100 µg |
EUR 550 |
Mouse Leukemia Inhibitory Factor (LIF) Protein |
|
20-abx067761 |
Abbexa |
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
|
- 10 ug
- 50 ug
- 100 ug
- 200 ug
- 1 mg
|
|
|
Mouse Leukemia Inhibitory Factor (LIF) Protein |
|
abx067761-10g |
Abbexa |
10 µg |
EUR 212.5 |
Mouse Leukemia Inhibitory Factor (LIF) Protein |
|
abx067761-50g |
Abbexa |
50 µg |
EUR 387.5 |
Mouse LIF Protein, His Tag (MALS verified) |
|
LIF-M5227 |
ACROBIOSYSTEMS |
1mg |
EUR 327 |
|
|
|
Description: Mouse LIF, His Tag (LIF-M5227) is expressed from human 293 cells (HEK293). It contains AA Ser 24 - Phe 203 (Accession # P09056-1). |
Mouse LIF Protein, Tag Free (MALS verified) |
|
LIF-M5219 |
ACROBIOSYSTEMS |
20ug |
EUR 2910.3 |
|
|
|
Description: Mouse LIF Protein, Tag Free (LIF-M5219) is expressed from human 293 cells (HEK293). It contains AA Ser 24 - Phe 203 (Accession # P09056-1). |
Recombinant Mouse Leukemia Inhibitory Factor/lIF |
|
AP75318 |
SAB |
1mg |
EUR 3209 |
|
|
Recombinant Mouse Leukemia inhibitory factor (Lif) |
|
MBS951573-002mgBaculovirus |
MyBiosource |
0.02mg(Baculovirus) |
EUR 1100 |
Recombinant Mouse Leukemia inhibitory factor (Lif) |
|
MBS951573-002mgEColi |
MyBiosource |
0.02mg(E-Coli) |
EUR 695 |
Recombinant Mouse Leukemia inhibitory factor (Lif) |
|
MBS951573-002mgYeast |
MyBiosource |
0.02mg(Yeast) |
EUR 855 |
Recombinant Mouse Leukemia inhibitory factor (Lif) |
|
MBS951573-01mgEColi |
MyBiosource |
0.1mg(E-Coli) |
EUR 810 |
Recombinant Mouse Leukemia inhibitory factor (Lif) |
|
MBS951573-01mgYeast |
MyBiosource |
0.1mg(Yeast) |
EUR 1000 |
Recombinant Mouse Leukemia Inhibitory Factor/lIF |
|
C690-10ug |
Novoprotein |
10ug |
EUR 175.2 |
|
Description: Lyophilized from a 0.2 μm filtered solution of 20mM PB,150mM NaCl,pH7.4. |
Recombinant Mouse Leukemia Inhibitory Factor/lIF |
|
C690-1mg |
Novoprotein |
1mg |
EUR 2739.6 |
|
Description: Lyophilized from a 0.2 μm filtered solution of 20mM PB,150mM NaCl,pH7.4. |
Recombinant Mouse Leukemia Inhibitory Factor/lIF |
|
C690-500ug |
Novoprotein |
500ug |
EUR 1935.6 |
|
Description: Lyophilized from a 0.2 μm filtered solution of 20mM PB,150mM NaCl,pH7.4. |
Recombinant Mouse Leukemia Inhibitory Factor/lIF |
|
C690-50ug |
Novoprotein |
50ug |
EUR 363.6 |
|
Description: Lyophilized from a 0.2 μm filtered solution of 20mM PB,150mM NaCl,pH7.4. |
Recombinant Mouse Leukemia Inhibitory Factor (Lif) |
|
AP2C589 |
BioVenic |
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
|
|
Recombinant Mouse LIF (Recombinant Mouse Leukemia inhibitory Factor) |
|
C0936-10μg |
Beyotime Biotech Inc |
100 µL |
Ask for price |
Recombinant Mouse LIF (Recombinant Mouse Leukemia inhibitory Factor) |
|
C0936-200μg |
Beyotime Biotech Inc |
2 mL |
Ask for price |
Recombinant Mouse LIF (Recombinant Mouse Leukemia inhibitory Factor) |
|
C0936-50μg |
Beyotime Biotech Inc |
500 µL |
Ask for price |
LIF Protein Vector (Mouse) (pPM-C-HA) |
|
PV196580 |
ABM |
500 ng |
EUR 723.6 |
LIF Protein Vector (Mouse) (pPM-C-HA) |
|
PV196584 |
ABM |
500 ng |
EUR 723.6 |
Mouse LIF -Leukemia Inhibitory Factor- CLIA Kit |
|
E-CL-M0038-24Tests |
Elabscience Biotech |
24 Tests |
EUR 180 |
|
|
|
Description: Sandwich |
Mouse LIF -Leukemia Inhibitory Factor- CLIA Kit |
|
E-CL-M0038-48Tests |
Elabscience Biotech |
48 Tests |
EUR 546 |
|
|
|
Description: Sandwich |
Mouse LIF -Leukemia Inhibitory Factor- CLIA Kit |
|
E-CL-M0038-96Tests |
Elabscience Biotech |
96 Tests |
EUR 682 |
|
|
|
Description: Sandwich |
Mouse LIF -Leukemia Inhibitory Factor- CLIA Kit |
|
E-CL-M0038-96Tests10 |
Elabscience Biotech |
96 Tests *10 |
EUR 6820 |
|
|
|
Description: Sandwich |
Mouse LIF -Leukemia Inhibitory Factor- CLIA Kit |
|
E-CL-M0038-96Tests5 |
Elabscience Biotech |
96 Tests *5 |
EUR 3410 |
|
|
|
Description: Sandwich |
Mouse LIF (Leukemia Inhibitory Factor) CLIA Kit |
|
MBS2531217-5x96Tests |
MyBiosource |
5x96Tests |
EUR 2565 |
Mouse LIF (Leukemia Inhibitory Factor) CLIA Kit |
|
MBS2531217-96Tests |
MyBiosource |
96Tests |
EUR 560 |
LIF Protein Vector (Mouse) (pPB-C-His) |
|
PV196578 |
ABM |
500 ng |
EUR 723.6 |
LIF Protein Vector (Mouse) (pPB-N-His) |
|
PV196579 |
ABM |
500 ng |
EUR 723.6 |
LIF Protein Vector (Mouse) (pPM-C-His) |
|
PV196581 |
ABM |
500 ng |
EUR 723.6 |
The redirected HSCs promote endogenous restore, resulting in elevated cardiac perform. The restore mechanism entails angiomyogenesis and irritation modulation. As well as, the inhalation route is superior to the intravenous path to ship PT-BsAbs by way of the HSCs’ homing potential and therapeutic advantages. This work demonstrates that this novel inhalable antibody remedy, which harnesses platelets derived from the lungs, contributes to potent stem cell redirection and coronary heart restore. This technique is secure and efficient in a mouse mannequin of MI.